- Company Profiles
- Target Profiles
- Product Profiles
Explore BCIQ profiles by entering a target name.
BioCentury | Oct 21, 2022
Data Byte
Addiction drug development activity doesn’t reflect the need
Innovative targets, approaches are breaking through, but clinical landscape remains vastly underpopulated
BioCentury | Jan 16, 2020
Company News
Jan. 15 Company Quick Takes: Japan Tobacco gets rights to Dermavant therapy; plus Clovis, BMS, Recordati, BeiGene, Insilico-Pfizer, Novartis
Items per page:
1 - 10 of 11